Rang	Name	Position
1	Dr. Alfred W. Sandrock Jr., M.D., Ph.D.	President, CEO & Director
2	Ms. Robin Swartz	Principal Financial Officer, Treasurer, Chief Business Officer & COO
3	Dr. Krystof Bankiewicz M.D., Ph.D.	Founder
4	Dr. Mark A. Kay M.D., Ph.D.	Founder
5	Ms. Amy Quinlan	Principal Accounting Officer
6	Mr. Todd Carter Ph.D.	Chief Scientific Officer
7	Ms. Trista Morrison	Chief Corporate Affairs Officer & Chief of Staff to the CEO
8	Dr. Mathieu Nonnenmacher Ph.D.	Vice President of Gene Therapy
9	Mihalis Kariolis	Vice President of Non-Viral Therapeutics

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	9,04%	17,76 Mio. USD
2	Millennium Management LLC	7,21%	14,17 Mio. USD
3	Armistice Capital, LLC	5,68%	11,17 Mio. USD
4	Vestal Point Capital LP	4,87%	9,58 Mio. USD
5	Vanguard Capital Management, LLC	3,71%	7,28 Mio. USD
6	Opaleye Management Inc	1,92%	3,78 Mio. USD
7	Erste Asset Management GmbH	1,78%	3,49 Mio. USD
8	Geode Capital Management, LLC	1,70%	3,35 Mio. USD
9	Two Sigma Investments LLC	1,54%	3,03 Mio. USD
10	State Street Corp	1,54%	3,03 Mio. USD
11	Dimensional Fund Advisors, Inc.	1,36%	2,67 Mio. USD
12	Citadel Advisors Llc	1,27%	2,50 Mio. USD
13	Vanguard Portfolio Management, LLC	1,18%	2,32 Mio. USD
14	Morgan Stanley - Brokerage Accounts	1,11%	2,18 Mio. USD
15	Renaissance Technologies Corp	0,94%	1,84 Mio. USD
16	Sphera Funds Management Ltd.	0,76%	1,50 Mio. USD
17	The Goldman Sachs Group Inc	0,69%	1,36 Mio. USD
18	Diadema Partners LP	0,67%	1,32 Mio. USD
19	Northern Trust Corp	0,62%	1,23 Mio. USD
20	Fiduciary Trust Co	0,54%	1,07 Mio. USD